An evaluation of the effectiveness of a multi-modal intervention in frail and pre-frail older people with type 2 diabetes - the MID-Frail study: study protocol for a randomised controlled trial

详细信息    查看全文

• 作者：Leocadio Rodríguez-Ma?as (1)
  Antony J Bayer (3)
  Mark Kelly (4)
  Andrej Zeyfang (5)
  Mikel Izquierdo (6)
  Olga Laosa (2)
  Timothy C Hardman (7)
  Alan J Sinclair (8)
  
• 关键词：Multi ; modal intervention ; Frail ; Pre ; frail ; Type 2 diabetes
• 刊名：Trials
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：15
• 期：1
• 全文大小：609 KB
• 作者单位：Leocadio Rodríguez-Ma?as (1)
  Antony J Bayer (3)
  Mark Kelly (4)
  Andrej Zeyfang (5)
  Mikel Izquierdo (6)
  Olga Laosa (2)
  Timothy C Hardman (7)
  Alan J Sinclair (8)
  
  1. Division of Geriatrics, Hospital Universitario de Getafe, Carretera de Toledo Km 12.5, 28905, Getafe, Spain
  3. Institute of Primary Care and Public Health, School of Medicine, Cardiff University and Memory Team, Cardiff and Vale University Health Board, Cardiff, CF14 4YS, UK
  4. Institute of Translation, Innovation, Methodology and Engagement (TIME), South East Wales Trials Unit, School of Medicine, Cardiff University, Cardiff, CF14 4XN, UK
  5. Institue of Epidemiology, University of Ulm, Albert-Einstein-Allee 41, 89081, Ulm, Germany
  6. Department of Health Sciences, Public University of Navarre, Campus of Tudela, 31500, Tudela, Spain
  2. Fundación para la Investigación Biomédica, Hospital Universitario de Getafe, Carretera de Toledo Km 12.5, 28905, Getafe, Spain
  7. Niche Science & Technology, Unit 26, Falstaff House, Bardolph Road, Richmond, TW9 2LH, UK
  8. Institute of Diabetes for Older People (IDOP), University of Bedfordshire, Putteridge Bury Campus, Hitchin Road, Luton, Bedfordshire, LU2 8LE, UK
  
• ISSN：1745-6215

文摘

Background Diabetes, a highly prevalent, chronic disease, is associated with increasing frailty and functional decline in older people, with concomitant personal, social, and public health implications. We describe the rationale and methods of the multi-modal intervention in diabetes in frailty (MID-Frail) study. Methods/Design The MID-Frail study is an open, randomised, multicentre study, with random allocation by clusters (each trial site) to a usual care group or an intervention group. A total of 1,718 subjects will be randomised with each site enrolling on average 14 or 15 subjects. The primary objective of the study is to evaluate, in comparison with usual clinical practice, the effectiveness of a multi-modal intervention (specific clinical targets, education, diet, and resistance training exercise) in frail and pre-frail subjects aged ?0?years with type 2 diabetes in terms of the difference in function 2 years post-randomisation. Difference in function will be measured by changes in a summary ordinal score on the short physical performance battery (SPPB) of at least one point. Secondary outcomes include daily activities, economic evaluation, and quality of life. Discussion The MID-Frail study will provide evidence on the clinical, functional, social, and economic impact of a multi-modal approach in frail and pre-frail older people with type 2 diabetes. Trial registration ClinicalTrials.gov: NCT01654341.